Genmab — Maj 2023
-
Ofte ser man biotech aktier stige frem mod mulig godkendelse. Genmab går i den anden retning. Nogen der ved om der er analytikere der hælder til et nej i denne omgang?
-
small new trial: Daratumumab in Acquired Hemophilia A https://clinicaltrials.gov/ct2/show/NCT05849740
-
and another one: Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma https://clinicaltrials.gov/ct2/show/NCT05849610
-
Spotlight On: Chris Cozic, Executive Vice President & Chief People Officer, Genmab https://www.capitalanalyticsassociates.com/spotlight-on-chris-cozic-executive-vice-president-chief-people-officer-genmab/
-
Godmorgen

-
Her medd. og indbydelse til CC https://ir.genmab.com/events-and-presentations#content
-
Ja, det står der jo i meddelelsen
Plejer at tikke ind 27:01 
-
17:01 - sorry….
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind